1. Home
  2. TOMZ vs CTXR Comparison

TOMZ vs CTXR Comparison

Compare TOMZ & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

N/A

Current Price

$1.55

Market Cap

18.4M

Sector

Finance

ML Signal

N/A

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.52

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
CTXR
Founded
1979
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
18.9M
IPO Year
2009
2010

Fundamental Metrics

Financial Performance
Metric
TOMZ
CTXR
Price
$1.55
$0.52
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
109.1K
299.1K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
13.64
43.38
EPS
N/A
N/A
Revenue
$5,635,927.00
N/A
Revenue This Year
$48.56
N/A
Revenue Next Year
$121.37
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.47
52 Week High
$2.12
$2.19

Technical Indicators

Market Signals
Indicator
TOMZ
CTXR
Relative Strength Index (RSI) 69.76 43.66
Support Level $0.62 $0.48
Resistance Level N/A $0.62
Average True Range (ATR) 0.13 0.04
MACD 0.10 0.00
Stochastic Oscillator 64.24 31.79

Price Performance

Historical Comparison
TOMZ
CTXR

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: